HMOX1 and diabetic cardiomyopathy: Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I<i>κ</i>B<i>α</i>/NF<i>κ</i>B and Enhancing Nrf2/HO-1".